{"lastClose": 1.690000057220459, "len": 431, "date": "2022-12-30", "alpha_1": -0.619203660911751, "beta_1": 2.5102083810596545, "drawup_1": 0.6999999674883763, "natr_1": 26.88600062857136, "sup_1": -0.05917163324997635, "res_1": 0.923076810939528, "bullPattern_1": ["SHORTLINE"], "bearPattern_1": [], "rsi_1": 28.31858355732548, "adx_1": 57.164125160506906, "drawdown_1": -0.812428069742239, "stratHoldSharpe_1": -1.1693831570369337, "stratHoldAlpha_1": 250.05668419373376, "stratHoldDrawdown_1": -0.7343966566306733, "alpha_3mo": -0.9418354822750139, "beta_3mo": 2.085447473864398, "drawup_3mo": 0.23913041900822218, "natr_3mo": 26.88600062857136, "sup_3mo": -0.12031560411456844, "res_3mo": 0.07297830221712343, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 41.55844296587101, "adx_3mo": 21.174359475971333, "drawdown_3mo": -0.495356041607954, "stratHoldSharpe_3mo": -2.977196496835704, "stratHoldAlpha_3mo": 248.8691641373114, "stratHoldDrawdown_3mo": -0.4458204374471586, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 3278565972, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "IPO Year": 2021.0, "Country": "United States", "alpha%_1": 0.06219200123572405, "beta%_1": 0.9982359583914178, "drawup%_1": 0.7594357571848416, "natr%_1": 1.0, "drawdown%_1": 0.02364224570015699, "stratHoldSharpe%_1": 0.1231361594957252, "stratHoldAlpha%_1": 0.004171023633534954, "stratHoldDrawdown%_1": 0.025021167911315735, "alpha%_3mo": 0.06982902501333565, "beta%_3mo": 0.9811908231158339, "drawup%_3mo": 0.4638944778017311, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0010128666073764847, "stratHoldSharpe%_3mo": 0.014431947751023504, "stratHoldAlpha%_3mo": 1.7243268848603493e-05, "stratHoldDrawdown%_3mo": 0.0011256061276475244}